HF4349 (Legislative Session 94 (2025-2026))
Provisions governing hospital reimbursement for biological products to treat rare diseases modified.
Related bill: SF4521
Bill text versions
- Introduction PDF PDF file
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| March 16, 2026 | House | Action | Introduction and first reading, referred to | Health Finance and Policy |
Progress through the legislative process
In Committee